Items where Author is "Swiss, Group for Clinical Cancer Research"

2008

Borner, M. and Koeberle, D. and Von Moos, R. and Saletti, P. and Rauch, D. and Hess, V. and Trojan, A. and Helbling, D. and Pestalozzi, B. and Caspar, C. and Ruhstaller, T. and Roth, A. and Kappeler, A. and Dietrich, D. and Lanz, D. and Mingrone, W. and Swiss, Group for Clinical Cancer Research and Bern, and Switzerland, . (2008) Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer : a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology, Vol. 19, H. 7. pp. 1288-1292.

Koeberle, D. and Saletti, P. and Borner, M. and Gerber, D. and Dietrich, D. and Caspar, C. B. and Mingrone, W. and Beretta, K. and Strasser, F. and Ruhstaller, T. and Mora, O. and Herrmann, R. and Swiss, Group for Clinical Cancer Research. (2008) Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine : a multicenter, phase II trial of the swiss group for clinical cancer research. Journal of clinical oncology, Vol. 26. pp. 3702-3708.

Zenhäusern, R. and Simcock, M. and Gratwohl, A. and Hess, U. and Bargetzi, M. and Tobler, A. and Swiss, Group for Clinical Cancer Research. (2008) Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). Haematologica, Vol. 93, H. 9. pp. 1426-1428.